Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery

被引:82
|
作者
Kheterpal, Sachin [1 ]
Khodaparast, Omeed [2 ]
Shanks, Amy [1 ]
O'Reilly, Michael [1 ]
Tremper, Kevin K. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48103 USA
[2] Baylor Univ, Med Ctr, Dept Anesthesiol, Dallas, TX 75246 USA
关键词
angiotensin-converting enzyme inhibitor; intraoperative hypotension; diuretics;
D O I
10.1053/j.jvca.2007.12.020
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Chronic angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) therapy has been reported to result in intraoperative hypotension in patients undergoing general anesthesia. This study evaluated the association between ACE-I/ARB therapy and the hemodynamics of patients undergoing noncardiac surgery using a large patient dataset. Design and Setting: A prospective, observational study performed at a single tertiary care hospital. Participants: All adult patients undergoing noncardiac surgery. Interventions: None. Measurements and Main Results: Propensity score matching for the likelihood of chronic ACE-I/ARB therapy was used to create 2 patient cohorts with similar cardiovascular and pulmonary comorbidities. The number of periods of absolute and relative hypotension, vasopressor requirements, and postoperative myocardial infarction and renal failure rates were compared among patients with and without ACE-I/ARB therapy. A total of 65,043 noncardiac cases be-tween 2003 and 2006 were included. Two-digit propensity score matching resulted in a study population of 12,381 operative cases with very similar cardiovascular comorbidities between the ACE-I/ARB and control cohort. Patients with chronic ACE-I/ARB and diuretic therapy showed more periods with a mean arterial pressure <70 mmHg, periods with a 40% decrease in systolic blood pressure, periods with a 50% decrease in systolic blood pressure, and vasopressor boluses when compared with patients with diuretic therapy alone. There were no statistically significant differences in the rates of postoperative myocardial infarction or renal failure between patients with and without ACE-I/ARB therapy. Conclusions: Chronic diuretic therapy is associated with more frequent hypotension in ACE-I/ARB-treated patients undergoing noncardiac surgery. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [31] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [32] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [33] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [34] Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity
    Tisminetzky, Mayra
    Gurwitz, Jerry H.
    Tabada, Grace
    Reynolds, Kristi
    Fortmann, Stephen P.
    Garcia, Elisha
    Pham, Thu
    Goldberg, Robert
    Go, Alan S.
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (12): : 1468 - 1477
  • [35] The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection
    Erlandson, Kristine M.
    Kitch, Douglas
    Wester, C. William
    Kalayjian, Robert C.
    Overton, Edgar Turner
    Castillo-Mancilla, Jose
    Koletar, Susan L.
    Benson, Constance A.
    Campbell, Thomas B.
    Robertson, Kevin
    Lok, Judith J.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (12) : 2042 - 2049
  • [36] Angiotensin-converting enzyme inhibitor/angiotensinIIreceptor blocker treatment and haemodynamic factors are associated with increased cardiacmRNAexpression of angiotensin-converting enzyme2in patients with cardiovascular disease
    Lebek, Simon
    Tafelmeier, Maria
    Messmann, Rebecca
    Provaznik, Zdenek
    Schmid, Christof
    Maier, Lars S.
    Birner, Christoph
    Arzt, Michael
    Wagner, Stefan
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2248 - 2257
  • [37] Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy
    Korniyenko, Aleksandr
    Alviar, Carlos L.
    Cordova, Juan P.
    Messerli, Franz H.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2011, 78 (05) : 297 - 304
  • [38] Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk
    Makar, George A.
    Holmes, John H.
    Yang, Yu-Xiao
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [39] Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
    Sato, A
    Saruta, T
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (09) : 781 - 788
  • [40] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M. A.
    White, W. B.
    Perez, A.
    Cao, C.
    Handley, A.
    Kupfer, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 479 - 486